Affygility Solutions, a global occupational health and safety consulting firm for the life sciences industry, has announced the launch of health-based exposure limits (HBEL) monographs for natural health products (NHP) to address the nutraceutical and herbal medicinal markets.
“As the natural health product industry continues its upward trajectory, the need for increased toxicology expertise and resources will also rise. With Affygility’s knowledge of the complex regulations in the pharmaceutical industry, we are able to help our clients understand the toxicology requirements in the natural health product market,” said Dean Calhoun, CIH, President and CEO of Affygility Solutions. “Natural doesn’t always equal safe.”
Since 2002, the company has supported toxicology services while complying with international regulations including European Medicines Agency (EMA), Pharmaceutical Inspection Co-operation Scheme (PIC/S), Brazilian Health Regulatory Agency (ANVISA) and the WHO.
